TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 1 | -1 | -7 | 0 | -8 | -9 | -14 | -8 |
S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/1/22 16:55 | 2/28/22 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hart Jayne B. | UT | O | Chief Pe | S.d | -263 | 25.00 | 0 | -11 | -6 | 166 | D | ||||||||||||||
9/21/21 18:18 | 9/17/21 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hart Jayne B. | UT | O | Chief Pe | S.d | -2,274 | 33.72 | 0 | -67 | -43 | 90 | D | ||||||||||||||
3/30/21 18:31 | 3/29/21 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hart Jayne B. | UT | O | Chief Pe | S.d | -1,740 | 30.00 | 0 | -58 | -42 | 80 | D | ||||||||||||||
4/7/14 16:44 | 4/7/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hart Jayne B. | UT | O | EVP HR | S.d | -3,231 | 40.90 | 33 | -79 | -99 | 1 | D | 72 | 67 | 65 | 93 | 7 | 17 | 25 | 17 | -1 | -7 | 0 | -8 | -9 | -14 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |